Arkolith/Insider Trading/PCVX/Form 4

Guggenhime Andrew

PRESIDENT AND CFOVaxcyte, Inc. (PCVX) · full profile →Form 4 · filed Mar 2, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 2, 2026Tax withholding(F)1K$61.98$63K105K
Feb 28, 2026Tax withholding(F)898$61.98$56K106K
Feb 26, 2026Grant(A)45K—$0107K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 26, 2026Grant(A)75K—$075K

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001230724-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML